Peter Kiessling

1PUBLICATIONS
4CO-AUTHORS
Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 03, 2017
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

Peter Kiessling, Rocio Lledo-Garcia, Shikiko Watanabe

Pageof 1